ID   LOQS_DROME              Reviewed;         465 AA.
AC   Q9VJY9; M9MRT5; Q4TZM6; Q8IP72; Q8SZ74;
DT   08-NOV-2023, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2002, sequence version 2.
DT   08-NOV-2023, entry version 180.
DE   RecName: Full=Protein Loquacious {ECO:0000303|PubMed:19644447};
GN   Name=loqs {ECO:0000303|PubMed:19644447, ECO:0000312|FlyBase:FBgn0032515};
GN   Synonyms=dRax {ECO:0000312|EMBL:AAF53295.2},
GN   loq {ECO:0000312|EMBL:AAF53295.2}, r3d1 {ECO:0000303|PubMed:15985611},
GN   TRBP {ECO:0000312|EMBL:AAF53295.2};
GN   ORFNames=CG6866 {ECO:0000312|FlyBase:FBgn0032515};
OS   Drosophila melanogaster (Fruit fly).
OC   Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Hexapoda; Insecta; Pterygota;
OC   Neoptera; Endopterygota; Diptera; Brachycera; Muscomorpha; Ephydroidea;
OC   Drosophilidae; Drosophila; Sophophora.
OX   NCBI_TaxID=7227 {ECO:0000312|Proteomes:UP000000803};
RN   [1] {ECO:0000312|EMBL:AAZ40191.1, ECO:0000312|EMBL:AAZ40192.1}
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS PB AND PD), FUNCTION (ISOFORM PB),
RP   IDENTIFICATION IN THE MIRNA-RISC LOADING COMPLEX (ISOFORM PB), AND
RP   SUBCELLULAR LOCATION.
RX   PubMed=15985611; DOI=10.1101/gad.1334005;
RA   Jiang F., Ye X., Liu X., Fincher L., McKearin D., Liu Q.;
RT   "Dicer-1 and R3D1-L catalyze microRNA maturation in Drosophila.";
RL   Genes Dev. 19:1674-1679(2005).
RN   [2] {ECO:0000312|Proteomes:UP000000803}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Berkeley {ECO:0000312|Proteomes:UP000000803};
RX   PubMed=10731132; DOI=10.1126/science.287.5461.2185;
RA   Adams M.D., Celniker S.E., Holt R.A., Evans C.A., Gocayne J.D.,
RA   Amanatides P.G., Scherer S.E., Li P.W., Hoskins R.A., Galle R.F.,
RA   George R.A., Lewis S.E., Richards S., Ashburner M., Henderson S.N.,
RA   Sutton G.G., Wortman J.R., Yandell M.D., Zhang Q., Chen L.X., Brandon R.C.,
RA   Rogers Y.-H.C., Blazej R.G., Champe M., Pfeiffer B.D., Wan K.H., Doyle C.,
RA   Baxter E.G., Helt G., Nelson C.R., Miklos G.L.G., Abril J.F., Agbayani A.,
RA   An H.-J., Andrews-Pfannkoch C., Baldwin D., Ballew R.M., Basu A.,
RA   Baxendale J., Bayraktaroglu L., Beasley E.M., Beeson K.Y., Benos P.V.,
RA   Berman B.P., Bhandari D., Bolshakov S., Borkova D., Botchan M.R., Bouck J.,
RA   Brokstein P., Brottier P., Burtis K.C., Busam D.A., Butler H., Cadieu E.,
RA   Center A., Chandra I., Cherry J.M., Cawley S., Dahlke C., Davenport L.B.,
RA   Davies P., de Pablos B., Delcher A., Deng Z., Mays A.D., Dew I.,
RA   Dietz S.M., Dodson K., Doup L.E., Downes M., Dugan-Rocha S., Dunkov B.C.,
RA   Dunn P., Durbin K.J., Evangelista C.C., Ferraz C., Ferriera S.,
RA   Fleischmann W., Fosler C., Gabrielian A.E., Garg N.S., Gelbart W.M.,
RA   Glasser K., Glodek A., Gong F., Gorrell J.H., Gu Z., Guan P., Harris M.,
RA   Harris N.L., Harvey D.A., Heiman T.J., Hernandez J.R., Houck J., Hostin D.,
RA   Houston K.A., Howland T.J., Wei M.-H., Ibegwam C., Jalali M., Kalush F.,
RA   Karpen G.H., Ke Z., Kennison J.A., Ketchum K.A., Kimmel B.E., Kodira C.D.,
RA   Kraft C.L., Kravitz S., Kulp D., Lai Z., Lasko P., Lei Y., Levitsky A.A.,
RA   Li J.H., Li Z., Liang Y., Lin X., Liu X., Mattei B., McIntosh T.C.,
RA   McLeod M.P., McPherson D., Merkulov G., Milshina N.V., Mobarry C.,
RA   Morris J., Moshrefi A., Mount S.M., Moy M., Murphy B., Murphy L.,
RA   Muzny D.M., Nelson D.L., Nelson D.R., Nelson K.A., Nixon K., Nusskern D.R.,
RA   Pacleb J.M., Palazzolo M., Pittman G.S., Pan S., Pollard J., Puri V.,
RA   Reese M.G., Reinert K., Remington K., Saunders R.D.C., Scheeler F.,
RA   Shen H., Shue B.C., Siden-Kiamos I., Simpson M., Skupski M.P., Smith T.J.,
RA   Spier E., Spradling A.C., Stapleton M., Strong R., Sun E., Svirskas R.,
RA   Tector C., Turner R., Venter E., Wang A.H., Wang X., Wang Z.-Y.,
RA   Wassarman D.A., Weinstock G.M., Weissenbach J., Williams S.M., Woodage T.,
RA   Worley K.C., Wu D., Yang S., Yao Q.A., Ye J., Yeh R.-F., Zaveri J.S.,
RA   Zhan M., Zhang G., Zhao Q., Zheng L., Zheng X.H., Zhong F.N., Zhong W.,
RA   Zhou X., Zhu S.C., Zhu X., Smith H.O., Gibbs R.A., Myers E.W., Rubin G.M.,
RA   Venter J.C.;
RT   "The genome sequence of Drosophila melanogaster.";
RL   Science 287:2185-2195(2000).
RN   [3] {ECO:0000312|Proteomes:UP000000803}
RP   GENOME REANNOTATION.
RC   STRAIN=Berkeley {ECO:0000312|Proteomes:UP000000803};
RX   PubMed=12537572; DOI=10.1186/gb-2002-3-12-research0083;
RA   Misra S., Crosby M.A., Mungall C.J., Matthews B.B., Campbell K.S.,
RA   Hradecky P., Huang Y., Kaminker J.S., Millburn G.H., Prochnik S.E.,
RA   Smith C.D., Tupy J.L., Whitfield E.J., Bayraktaroglu L., Berman B.P.,
RA   Bettencourt B.R., Celniker S.E., de Grey A.D.N.J., Drysdale R.A.,
RA   Harris N.L., Richter J., Russo S., Schroeder A.J., Shu S.Q., Stapleton M.,
RA   Yamada C., Ashburner M., Gelbart W.M., Rubin G.M., Lewis S.E.;
RT   "Annotation of the Drosophila melanogaster euchromatic genome: a systematic
RT   review.";
RL   Genome Biol. 3:RESEARCH0083.1-RESEARCH0083.22(2002).
RN   [4] {ECO:0000312|EMBL:AAL48692.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM PB).
RC   STRAIN=Berkeley; TISSUE=Embryo;
RX   PubMed=12537569; DOI=10.1186/gb-2002-3-12-research0080;
RA   Stapleton M., Carlson J.W., Brokstein P., Yu C., Champe M., George R.A.,
RA   Guarin H., Kronmiller B., Pacleb J.M., Park S., Wan K.H., Rubin G.M.,
RA   Celniker S.E.;
RT   "A Drosophila full-length cDNA resource.";
RL   Genome Biol. 3:RESEARCH0080.1-RESEARCH0080.8(2002).
RN   [5] {ECO:0000312|EMBL:AAY40789.1}
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM PC).
RA   Forstemann K., Tomari Y., Du T., Vagin V.V., Denli A.M., Bratu D.P.,
RA   Klattenhoff C., Theurkauf W.H., Zamore P.D.;
RT   "Normal microRNA maturation by Dicer-1 and germ-line stem cell maintenance
RT   requires the double-stranded RNA-binding domain protein, loquacious.";
RL   Submitted (APR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6] {ECO:0000305}
RP   PARTIAL NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM PD), FUNCTION (ISOFORM PD), AND
RP   INTERACTION WITH DCR-1 AND DCR-2 (ISOFORMS PA; PB AND PD).
RX   PubMed=19644447; DOI=10.1038/emboj.2009.220;
RA   Hartig J.V., Esslinger S., Boettcher R., Saito K., Foerstemann K.;
RT   "Endo-siRNAs depend on a new isoform of loquacious and target artificially
RT   introduced, high-copy sequences.";
RL   EMBO J. 28:2932-2944(2009).
RN   [7] {ECO:0000305}
RP   FUNCTION (ISOFORM PB), IDENTIFICATION IN THE MIRNA-RISC LOADING COMPLEX,
RP   AND SUBCELLULAR LOCATION.
RX   PubMed=15918769; DOI=10.1371/journal.pbio.0030235;
RA   Saito K., Ishizuka A., Siomi H., Siomi M.C.;
RT   "Processing of pre-microRNAs by the Dicer-1-Loquacious complex in
RT   Drosophila cells.";
RL   PLoS Biol. 3:e235-e235(2005).
RN   [8] {ECO:0000305}
RP   INTERACTION WITH DCR-1 (ISOFORMS PA AND PB), AND TISSUE SPECIFICITY
RP   (ISOFORMS PA; PB AND PC).
RX   PubMed=15918770; DOI=10.1371/journal.pbio.0030236;
RA   Foerstemann K., Tomari Y., Du T., Vagin V.V., Denli A.M., Bratu D.P.,
RA   Klattenhoff C., Theurkauf W.E., Zamore P.D.;
RT   "Normal microRNA maturation and germ-line stem cell maintenance requires
RT   Loquacious, a double-stranded RNA-binding domain protein.";
RL   PLoS Biol. 3:e236-e236(2005).
RN   [9] {ECO:0000305}
RP   FUNCTION (ISOFORMS PA AND PB), TISSUE SPECIFICITY (ISOFORM PB), AND
RP   DISRUPTION PHENOTYPE.
RX   PubMed=17320391; DOI=10.1016/j.cub.2007.01.060;
RA   Park J.K., Liu X., Strauss T.J., McKearin D.M., Liu Q.;
RT   "The miRNA pathway intrinsically controls self-renewal of Drosophila
RT   germline stem cells.";
RL   Curr. Biol. 17:533-538(2007).
RN   [10] {ECO:0000305}
RP   FUNCTION (ISOFORM PB), INTERACTION WITH DCR-1 (ISOFORMS PA AND PB), AND
RP   MUTAGENESIS OF 308-ALA-ALA-309 AND 440-SER--LYS-465.
RX   PubMed=17666393; DOI=10.1074/jbc.m705208200;
RA   Ye X., Paroo Z., Liu Q.;
RT   "Functional anatomy of the Drosophila microRNA-generating enzyme.";
RL   J. Biol. Chem. 282:28373-28378(2007).
RN   [11] {ECO:0000305}
RP   FUNCTION (ISOFORMS PA AND PB).
RX   PubMed=17928574; DOI=10.1261/rna.723707;
RA   Liu X., Park J.K., Jiang F., Liu Y., McKearin D., Liu Q.;
RT   "Dicer-1, but not Loquacious, is critical for assembly of miRNA-induced
RT   silencing complexes.";
RL   RNA 13:2324-2329(2007).
RN   [12] {ECO:0000305}
RP   IDENTIFICATION IN THE MIRNA-RISC LOADING COMPLEX (ISOFORM PB).
RX   PubMed=19451544; DOI=10.1261/rna.1541209;
RA   Miyoshi K., Okada T.N., Siomi H., Siomi M.C.;
RT   "Characterization of the miRNA-RISC loading complex and miRNA-RISC formed
RT   in the Drosophila miRNA pathway.";
RL   RNA 15:1282-1291(2009).
RN   [13] {ECO:0000305}
RP   FUNCTION (ISOFORMS PA; PB AND PD), AND INTERACTION WITH DCR-1 AND DCR-2
RP   (ISOFORMS PA; PB; PC AND PD).
RX   PubMed=19635780; DOI=10.1261/rna.1611309;
RA   Zhou R., Czech B., Brennecke J., Sachidanandam R., Wohlschlegel J.A.,
RA   Perrimon N., Hannon G.J.;
RT   "Processing of Drosophila endo-siRNAs depends on a specific Loquacious
RT   isoform.";
RL   RNA 15:1886-1895(2009).
RN   [14] {ECO:0000305}
RP   FUNCTION (ISOFORM PD), INTERACTION WITH DCR-2 (ISOFORM PD), AND MUTAGENESIS
RP   OF 338-VAL--ILE-359 (ISOFORM PD).
RX   PubMed=21245036; DOI=10.1093/nar/gkq1324;
RA   Hartig J.V., Foerstemann K.;
RT   "Loqs-PD and R2D2 define independent pathways for RISC generation in
RT   Drosophila.";
RL   Nucleic Acids Res. 39:3836-3851(2011).
RN   [15] {ECO:0000305}
RP   FUNCTION (ISOFORMS PA; PB AND PD), AND DISRUPTION PHENOTYPE (ISOFORMS PA;
RP   PB AND PC).
RX   PubMed=23063653; DOI=10.1016/j.cell.2012.09.027;
RA   Fukunaga R., Han B.W., Hung J.H., Xu J., Weng Z., Zamore P.D.;
RT   "Dicer partner proteins tune the length of mature miRNAs in flies and
RT   mammals.";
RL   Cell 151:533-546(2012).
RN   [16] {ECO:0000305}
RP   FUNCTION (ISOFORM PD).
RX   PubMed=25891075; DOI=10.1016/j.molcel.2015.03.012;
RA   Sinha N.K., Trettin K.D., Aruscavage P.J., Bass B.L.;
RT   "Drosophila dicer-2 cleavage is mediated by helicase- and dsRNA termini-
RT   dependent states that are modulated by Loquacious-PD.";
RL   Mol. Cell 58:406-417(2015).
RN   [17] {ECO:0000305}
RP   FUNCTION (ISOFORMS PA; PB AND PD).
RX   PubMed=27184838; DOI=10.1016/j.celrep.2016.04.059;
RA   Lim M.Y., Ng A.W., Chou Y., Lim T.P., Simcox A., Tucker-Kellogg G.,
RA   Okamura K.;
RT   "The Drosophila Dicer-1 Partner Loquacious Enhances miRNA Processing from
RT   Hairpins with Unstable Structures at the Dicing Site.";
RL   Cell Rep. 15:1795-1808(2016).
RN   [18] {ECO:0000305}
RP   FUNCTION (ISOFORM PD), INTERACTION WITH DCR-2 (ISOFORM PD), DOMAIN, AND
RP   MUTAGENESIS OF 338-VAL--ILE-359 (ISOFORM PD).
RX   PubMed=28874570; DOI=10.1073/pnas.1707063114;
RA   Trettin K.D., Sinha N.K., Eckert D.M., Apple S.E., Bass B.L.;
RT   "Loquacious-PD facilitates Drosophila Dicer-2 cleavage through interactions
RT   with the helicase domain and dsRNA.";
RL   Proc. Natl. Acad. Sci. U.S.A. 114:E7939-E7948(2017).
RN   [19] {ECO:0000305}
RP   FUNCTION (ISOFORM PD).
RX   PubMed=29550490; DOI=10.1016/j.bbrc.2018.03.108;
RA   Fukunaga R.;
RT   "Loquacious-PD removes phosphate inhibition of Dicer-2 processing of
RT   hairpin RNAs into siRNAs.";
RL   Biochem. Biophys. Res. Commun. 498:1022-1027(2018).
RN   [20] {ECO:0000305}
RP   FUNCTION (ISOFORMS PA AND PB).
RX   PubMed=29373753; DOI=10.1093/nar/gky043;
RA   Zhu L., Kandasamy S.K., Fukunaga R.;
RT   "Dicer partner protein tunes the length of miRNAs using base-mismatch in
RT   the pre-miRNA stem.";
RL   Nucleic Acids Res. 46:3726-3741(2018).
RN   [21] {ECO:0000305}
RP   FUNCTION (ISOFORM PD), AND DOMAIN.
RX   PubMed=34590626; DOI=10.1039/d1cc03843e;
RA   Jonely M., Singh R.K., Donelick H.M., Bass B.L., Noriega R.;
RT   "Loquacious-PD regulates the terminus-dependent molecular recognition of
RT   Dicer-2 toward double-stranded RNA.";
RL   Chem. Commun. (Camb.) 57:10879-10882(2021).
RN   [22] {ECO:0000305}
RP   FUNCTION (ISOFORM PD), AND INDUCTION (ISOFORM PD).
RX   PubMed=36057690; DOI=10.1038/s42003-022-03885-w;
RA   Porrazzo A., Cipressa F., De Gregorio A., De Pitta C., Sales G.,
RA   Ciapponi L., Morciano P., Esposito G., Tabocchini M.A., Cenci G.;
RT   "Low dose rate gamma-irradiation protects fruit fly chromosomes from double
RT   strand breaks and telomere fusions by reducing the esi-RNA biogenesis
RT   factor Loquacious.";
RL   Commun. Biol. 5:905-905(2022).
RN   [23] {ECO:0000305}
RP   ERRATUM OF PUBMED:36057690.
RX   PubMed=36175493; DOI=10.1038/s42003-022-03984-8;
RA   Porrazzo A., Cipressa F., De Gregorio A., De Pitta C., Sales G.,
RA   Ciapponi L., Morciano P., Esposito G., Tabocchini M.A., Cenci G.;
RL   Commun. Biol. 5:1033-1033(2022).
RN   [24] {ECO:0007744|PDB:4X8W}
RP   X-RAY CRYSTALLOGRAPHY (2.65 ANGSTROMS) OF 392-463, FUNCTION (ISOFORMS PA
RP   AND PB), SUBUNIT, INTERACTION WITH DCR-1 (ISOFORM PB), AND MUTAGENESIS OF
RP   379-LEU--LEU-382; PHE-419 AND LEU-426.
RX   PubMed=26769856; DOI=10.1261/rna.055426.115;
RA   Jakob L., Treiber T., Treiber N., Gust A., Kramm K., Hansen K., Stotz M.,
RA   Wankerl L., Herzog F., Hannus S., Grohmann D., Meister G.;
RT   "Structural and functional insights into the fly microRNA biogenesis factor
RT   Loquacious.";
RL   RNA 22:383-396(2016).
RN   [25] {ECO:0007744|PDB:5NPA}
RP   STRUCTURE BY NMR OF 252-318, FUNCTION (ISOFORM PD), DOMAIN, AND INTERACTION
RP   WITH DCR-2 (ISOFORM PD).
RX   PubMed=29040648; DOI=10.1093/nar/gkx886;
RA   Tants J.-N., Fesser S., Kern T., Stehle R., Geerlof A., Wunderlich C.,
RA   Juen M., Hartlmuller C., Boettcher R., Kunzelmann S., Lange O., Kreutz C.,
RA   Foerstemann K., Sattler M.;
RT   "Molecular basis for asymmetry sensing of siRNAs by the Drosophila Loqs-
RT   PD/Dcr-2 complex in RNA interference.";
RL   Nucleic Acids Res. 45:12536-12550(2017).
RN   [26] {ECO:0007744|PDB:8DFV, ECO:0007744|PDB:8DG5, ECO:0007744|PDB:8DG7, ECO:0007744|PDB:8DGA, ECO:0007744|PDB:8DGI, ECO:0007744|PDB:8DGJ}
RP   STRUCTURE BY ELECTRON MICROSCOPY (3.06 ANGSTROMS) IN COMPLEX WITH DCR-1,
RP   FUNCTION (ISOFORM PB), AND DOMAIN.
RX   PubMed=36182693; DOI=10.1016/j.molcel.2022.09.002;
RA   Jouravleva K., Golovenko D., Demo G., Dutcher R.C., Hall T.M.T.,
RA   Zamore P.D., Korostelev A.A.;
RT   "Structural basis of microRNA biogenesis by Dicer-1 and its partner protein
RT   Loqs-PB.";
RL   Mol. Cell 82:4049-4063.e6(2022).
RN   [27] {ECO:0007744|PDB:7W0A, ECO:0007744|PDB:7W0B}
RP   STRUCTURE BY ELECTRON MICROSCOPY (3.12 ANGSTROMS) (ISOFORM PD) IN COMPLEX
RP   WITH DCR-2, AND MUTAGENESIS OF TYR-347; PHE-356 AND ILE-359 (ISOFORM PD).
RX   PubMed=35768513; DOI=10.1038/s41586-022-04911-x;
RA   Su S., Wang J., Deng T., Yuan X., He J., Liu N., Li X., Huang Y.,
RA   Wang H.W., Ma J.;
RT   "Structural insights into dsRNA processing by Drosophila Dicer-2-Loqs-PD.";
RL   Nature 607:399-406(2022).
CC   -!- FUNCTION: [Isoform PA]: Double-stranded RNA-binding protein which can
CC       function in gene silencing by acting with Dcr-1 to enhance its ATP-
CC       independent processing of a specific subset of precursor micro-RNAs
CC       (pre-miRNAs) to mature miRNAs (PubMed:19635780, PubMed:27184838,
CC       PubMed:26769856). Some reports found it was able to enhance the
CC       efficiency of pre-miRNA processing by Dcr-1, and can shift the cleavage
CC       site of Dcr-1 altering the length of the mature miRNAs produced by Dcr-
CC       1 alone (PubMed:17320391, PubMed:23063653, PubMed:29373753). However,
CC       in contrast to isoform PB, it is not necessary or sufficient for
CC       enhancing miRNA biogenesis, and is not required for development or
CC       female germline stem cell (GSC) maintenance (PubMed:17320391,
CC       PubMed:23063653). Another report also found that it decreases binding
CC       of Dcr-1 to the miRNA substrate let-7 (PubMed:17928574).
CC       {ECO:0000269|PubMed:17320391, ECO:0000269|PubMed:17928574,
CC       ECO:0000269|PubMed:19635780, ECO:0000269|PubMed:23063653,
CC       ECO:0000269|PubMed:26769856, ECO:0000269|PubMed:27184838,
CC       ECO:0000269|PubMed:29373753}.
CC   -!- FUNCTION: [Isoform PB]: Double-stranded RNA-binding protein which
CC       functions in gene silencing by acting with Dcr-1 to enhance its ATP-
CC       independent processing of a specific subset of precursor micro-RNAs
CC       (pre-miRNAs) to mature miRNAs (PubMed:19635780, PubMed:27184838,
CC       PubMed:26769856, PubMed:17928574, PubMed:36182693, PubMed:15918769,
CC       PubMed:15985611, PubMed:17666393). Function is essential for
CC       development and female germline stem cell (GSC) maintenance
CC       (PubMed:17320391, PubMed:23063653, PubMed:15985611). Functions in
CC       miRNA-mediated gene silencing by enhancing the binding affinity and
CC       specific pre-miRNA processing activity of Dcr-1, and as part of the
CC       loqs-PB-Dcr-1 complex, is involved in substrate discrimination,
CC       correctly positioning the pre-miRNA in the Dcr-1 catalytic center for
CC       cleavage, and miRNA loading into the Argonaute 1 (Ago1)-containing RNA-
CC       induced silencing complex (miRISC) (PubMed:23063653, PubMed:27184838,
CC       PubMed:17928574, PubMed:36182693, PubMed:15918769, PubMed:17666393).
CC       Increases the binding affinity of Dcr-1 to pre-miRNAs, thereby
CC       increasing dicing efficiency and broadening the range of substrates
CC       that can be processed by the dicer (PubMed:23063653, PubMed:27184838,
CC       PubMed:17928574, PubMed:36182693). It may also confer the substrate
CC       specificity of Dcr-1 towards pre-miRNAs, as in its absence Dcr-1
CC       displays siRNA-generating activity towards long dsRNA substrates
CC       (PubMed:15918769). It can also shift the cleavage site of Dcr-1 for a
CC       small number of pre-miRNAs, changing the length of the mature miRNAs
CC       produced by Dcr-1 alone (PubMed:23063653, PubMed:29373753). Increases
CC       the range of pre-miRNAs that can be processed by Dcr-1, by enhancing
CC       the dicing of suboptimal hairpin substrates including ones with
CC       mismatches at the dicing site (PubMed:27184838, PubMed:29373753). This
CC       function may also promote the generation of novel miRNA genes as it
CC       appears to have an important role in processing evolutionarily young
CC       miRNA genes, suggesting that it may also enhance dicing of substrates
CC       that have not acquired hairpin features required for efficient miRNA
CC       processing (PubMed:27184838). As newly emerged miRNAs can have
CC       deleterious or beneficial effects on fitness, this function is likely
CC       part of a regulatory system that prevents excessive emergence of active
CC       miRNA genes and thus keeps them within an optimal range
CC       (PubMed:27184838). Also forms a RISC loading complex (miRLC) with Dcr-1
CC       to mediate Ago1-loading of mature miRNAs into the RNA-induced silencing
CC       complex (miRISC) (PubMed:36182693, PubMed:15918769). In female ovaries,
CC       required for Dcr-1 to generate the twenty-three nucleotide isomiR
CC       variant of miR-307a which is able to repress its targets Gk2 and tara
CC       (PubMed:23063653). {ECO:0000269|PubMed:15918769,
CC       ECO:0000269|PubMed:15985611, ECO:0000269|PubMed:17320391,
CC       ECO:0000269|PubMed:17666393, ECO:0000269|PubMed:17928574,
CC       ECO:0000269|PubMed:19635780, ECO:0000269|PubMed:23063653,
CC       ECO:0000269|PubMed:26769856, ECO:0000269|PubMed:27184838,
CC       ECO:0000269|PubMed:29373753, ECO:0000269|PubMed:36182693}.
CC   -!- FUNCTION: [Isoform PD]: Double-stranded RNA-binding protein which has
CC       an essential role in gene silencing (RNAi) by acting with Dcr-2 to
CC       enhance its ATP-dependent processing of a subset of endogenous (endo)
CC       and exogenous (exo) dsRNAs into short interfering RNAs (siRNAs)
CC       (PubMed:19644447, PubMed:21245036, PubMed:29040648, PubMed:28874570,
CC       PubMed:34590626, PubMed:29550490, PubMed:25891075, PubMed:27184838,
CC       PubMed:19635780, PubMed:23063653). Functions in RNAi by increasing the
CC       initial binding affinity of Dcr-2 to certain dsRNA substrates, and in
CC       the absence of r2d2, may also function in siRNA loading into the
CC       Argonaute 2 (AGO2)-containing RNA-induced silencing complex (siRISC)
CC       and guide strand selection for target silencing by the siRISC
CC       (PubMed:19644447, PubMed:21245036, PubMed:29550490, PubMed:19635780).
CC       Promotes Dcr-2 cleavage of a subset of dsRNAs, including endo-dsRNAs
CC       derived from convergent transcription, inverted repeats and transposons
CC       (PubMed:19644447, PubMed:21245036, PubMed:29550490, PubMed:19635780,
CC       PubMed:23063653). Also enables Dcr-2 to produce hairpin-derived endo-
CC       siRNAs in the presence of cellular inhibitory inorganic phosphate,
CC       likely by increasing the binding affinity of the enzyme to the hairpin
CC       dsRNAs allowing the dsRNA to displace phosphate bound to Dcr-2
CC       (PubMed:29550490). According to many reports, the cleavage reaction
CC       mode of Dcr-2 changes according to the termini of the dsRNA substrate,
CC       with the enzyme displaying a preference for processing blunt termini
CC       (BLT), likely non-self dsRNAs, over dsRNAs with 2 nucleotides 3'
CC       overhanging (3'ovr) termini, which are typically the structure of endo-
CC       dsRNAs (PubMed:29550490, PubMed:34590626, PubMed:25891075). According
CC       to many reports, interaction with Loqs-PD modifies the molecular
CC       recognition mechanisms of Dcr-2 towards sub-optimal 3'ovr dsRNA
CC       substrates and thus enables the dicer to cleave endo-dsRNA templates
CC       with diverse termini (PubMed:29550490, PubMed:25891075). However,
CC       according to another report, the mode of cleavage reaction is not
CC       affected by the presence or absence of loqs-PD (PubMed:34590626). In
CC       the absence of r2d2, may also form an alternative RISC loading complex
CC       (siRLC) with Dcr-2 to mediate AGO2-loading of endo- and exo-siRNAs into
CC       the RNA-induced silencing complex (siRISC) (PubMed:21245036,
CC       PubMed:29040648). Many reports suggest that loqs-PD and r2d2 function
CC       independently with dcr-2 in distinct siRNA pathways, and may even
CC       compete for binding to the enzyme (PubMed:21245036, PubMed:29040648).
CC       Loaded siRNAs serve as a guide to direct the siRISC to complementary
CC       RNAs to degrade them or prevent their translation (PubMed:29040648).
CC       The siRLC plays an important role in the ATP-dependent asymmetry
CC       sensing of the duplex, and is therefore also responsible for the
CC       selection of the strand that ultimately acts as the guide siRNA for the
CC       siRISC (PubMed:29040648). Thermodynamically asymmetric endo-siRNAs can
CC       be pre-oriented in the siRLC by the Loqs-PD and DCr-2 complex, which
CC       preferentially binds to the most thermodynamically stable strand prior
CC       to loading into the siRISC (PubMed:29040648). Appears to be involved in
CC       promoting double-strand breaks (DSBs) following exposure to a low-
CC       dose/dose-rate (LDR) of ionizing radiation (PubMed:36057690).
CC       {ECO:0000269|PubMed:19635780, ECO:0000269|PubMed:19644447,
CC       ECO:0000269|PubMed:21245036, ECO:0000269|PubMed:23063653,
CC       ECO:0000269|PubMed:25891075, ECO:0000269|PubMed:27184838,
CC       ECO:0000269|PubMed:28874570, ECO:0000269|PubMed:29040648,
CC       ECO:0000269|PubMed:29550490, ECO:0000269|PubMed:34590626,
CC       ECO:0000269|PubMed:36057690}.
CC   -!- SUBUNIT: Homodimer. {ECO:0000269|PubMed:29040648}.
CC   -!- SUBUNIT: [Isoform PA]: Interacts with dicer enzyme Dcr-1.
CC       {ECO:0000269|PubMed:15918770, ECO:0000269|PubMed:17666393,
CC       ECO:0000269|PubMed:19635780, ECO:0000269|PubMed:19644447}.
CC   -!- SUBUNIT: [Isoform PB]: Component of the miRNA-directed RNA-induced
CC       loading complex (miRLC), composed of at least Dcr-1, AGO1 and loqs
CC       isoform PB (loqs-PB), which processes pre-miRNAs and loads the
CC       resulting miRNAs into the Argonaute 1 (AGO1)-containing RNA-induced
CC       silencing complex (miRISC) to target the selective destruction of
CC       homologous RNAs (PubMed:19451544, PubMed:15918769, PubMed:15985611).
CC       Interacts (via DRBM 3 domain) with dicer enzyme Dcr-1 (via helicase
CC       domain) (PubMed:19644447, PubMed:19635780, PubMed:15918770,
CC       PubMed:17666393, PubMed:36182693, PubMed:15918769, PubMed:19451544,
CC       PubMed:15985611, PubMed:26769856). Different regions of the Dcr-1-loqs-
CC       PB heterodimer collaborate to recognize, bind and position the pre-
CC       miRNA for Dcr-1 mediated cleavage (PubMed:36182693). In the absence of
CC       miRNA substrates, the heterodimer favors a closed, catalytically
CC       incompetent, conformation, whereas binding of authentic pre-miRNA
CC       substrates stabilizes the relatively rare open, catalytically
CC       competent, conformation of the heterodimer (PubMed:36182693). During
CC       substrate recognition, the Dcr-1 PAZ domain and pre-miRNA interact with
CC       the DRBM 1 domain of loqs-PB, which likely contributes to substrate
CC       recognition and stabilization (PubMed:36182693). At the miRNA binding
CC       stage, the Dcr-1 DRBM domain and the loqs-PB DRBM domains then bind the
CC       pre-miRNA in tandem to form a tight 'belt' around the pre-miRNA stem,
CC       the pre-miRNA loop is docked in the loop-binding region formed by
CC       DUF283, DRBM and part of the helicase domain of Dcr-1, and the loqs-PB
CC       DRBM 1 and the wing domain of Dcr-1 act together to bind the 5' and 3'
CC       pre-miRNA termini within the PAZ and platform domains of Dcr-1
CC       (PubMed:36182693). These interactions between the proteins and their
CC       pre-miRNA substrate stabilize a distorted form of the pre-miRNA and
CC       position the scissile phosphodiester bonds of the pre-miRNA at the
CC       RNase III catalytic cleavage sites of Dcr-1 (PubMed:36182693).
CC       Following Dcr-1 mediated cleavage, the miRNA duplex remains bound to
CC       loqs-PB DRBM 1, which dissociates from the Dcr-1 RNase III 1 domain but
CC       remains in contact with the PAZ and wing domains suggesting that the
CC       heterodimer presents the mature miRNA to AGO2 for loading into the RNA-
CC       induced silencing complex (miRISC) (PubMed:36182693).
CC       {ECO:0000269|PubMed:15918769, ECO:0000269|PubMed:15918770,
CC       ECO:0000269|PubMed:15985611, ECO:0000269|PubMed:17666393,
CC       ECO:0000269|PubMed:19451544, ECO:0000269|PubMed:19635780,
CC       ECO:0000269|PubMed:19644447, ECO:0000269|PubMed:26769856,
CC       ECO:0000269|PubMed:36182693}.
CC   -!- SUBUNIT: [Isoform PC]: Able to interact with dicer enzyme Dcr-1
CC       (PubMed:17666393). However, the relevance of such an interaction is
CC       unclear in vivo and another report found that it did not interact with
CC       Dcr-1 (PubMed:19635780). {ECO:0000269|PubMed:17666393,
CC       ECO:0000269|PubMed:19635780}.
CC   -!- SUBUNIT: [Isoform PD]: Monomer (PubMed:28874570). Interacts (via C-
CC       terminus) with dicer enzyme Dcr-2 (via N-terminus); interaction is
CC       required for RNAi activity in producing siRNAs from a subset of
CC       endo- and exo-dsRNAs, and in the alternative siRLC, the interaction
CC       enhances the binding preference of the protein for the
CC       thermodynamically more stable ends of endogenous siRNAs
CC       (PubMed:19644447, PubMed:19635780, PubMed:21245036, PubMed:28874570,
CC       PubMed:35768513, PubMed:29040648). Interaction with Dcr-2 is RNA
CC       independent, however the isoform must bind both dsRNA and Dcr-2 to
CC       enhance Dcr-2 cleavage activity (PubMed:28874570). Does not interact
CC       with Dcr-1 (PubMed:19644447). {ECO:0000269|PubMed:19635780,
CC       ECO:0000269|PubMed:19644447, ECO:0000269|PubMed:21245036,
CC       ECO:0000269|PubMed:28874570, ECO:0000269|PubMed:29040648,
CC       ECO:0000269|PubMed:35768513}.
CC   -!- INTERACTION:
CC       Q9VJY9; Q9VCU9: Dcr-1; NbExp=12; IntAct=EBI-638074, EBI-112170;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:15918769}.
CC       Cytoplasm, cytosol {ECO:0000269|PubMed:15985611}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=PB {ECO:0000303|PubMed:19644447, ECO:0000312|FlyBase:FBgn0032515};
CC       Synonyms=loqs-PB {ECO:0000303|PubMed:19644447}, r3d1-L
CC       {ECO:0000303|PubMed:15985611};
CC         IsoId=Q9VJY9-1; Sequence=Displayed;
CC       Name=PA {ECO:0000303|PubMed:19644447, ECO:0000312|FlyBase:FBgn0032515};
CC       Synonyms=loqs-PA {ECO:0000303|PubMed:19644447}, r3d1-S
CC       {ECO:0000303|PubMed:15985611};
CC         IsoId=Q9VJY9-2; Sequence=VSP_062002;
CC       Name=PC {ECO:0000303|PubMed:19644447, ECO:0000312|FlyBase:FBgn0032515};
CC       Synonyms=loqs-PC {ECO:0000303|PubMed:19644447};
CC         IsoId=Q9VJY9-3; Sequence=VSP_062003, VSP_062006;
CC       Name=PD {ECO:0000303|PubMed:19644447, ECO:0000312|FlyBase:FBgn0032515};
CC       Synonyms=loqs-PD {ECO:0000303|PubMed:19644447};
CC         IsoId=Q9VJY9-4; Sequence=VSP_062004, VSP_062005;
CC   -!- TISSUE SPECIFICITY: [Isoform PA]: Strong expression in males and
CC       females (PubMed:15918770). Expression in ovaries is relatively weak
CC       (PubMed:15918770). {ECO:0000269|PubMed:15918770}.
CC   -!- TISSUE SPECIFICITY: [Isoform PB]: Strong expression in females and
CC       relatively weak expression in males (PubMed:15918770). Strong
CC       expression in ovaries (PubMed:15918770). {ECO:0000269|PubMed:15918770}.
CC   -!- DEVELOPMENTAL STAGE: [Isoform PA]: Expressed both maternally and
CC       zygotically (at protein level). Detected in embryos, larvae and adults
CC       (at protein level). {ECO:0000269|PubMed:17320391}.
CC   -!- DEVELOPMENTAL STAGE: [Isoform PB]: Expressed both maternally and
CC       zygotically (at protein level). Detected in embryos, larvae and adults
CC       (at protein level). {ECO:0000269|PubMed:17320391}.
CC   -!- INDUCTION: [Isoform PD]: Slightly down-regulated in response to a low-
CC       dose/dose-rate (LDR) of ionizing radiation.
CC       {ECO:0000269|PubMed:36057690}.
CC   -!- DOMAIN: RNA-binding DRBM domains 1 and 2 bind dsRNA while DRBM 3 binds
CC       Dcr-1 (PubMed:34590626, PubMed:29040648, PubMed:36182693). The RNA-
CC       binding DRBM 1 and 2 domains are able to bind dsRNA independently
CC       (PubMed:34590626). The DRBM domains appears to bind to the RNA duplex
CC       and then slide along the siRNA helix to the ends of the siRNA
CC       (PubMed:29040648). The DRBMs display a preference for binding to the
CC       more thermodynamically stable ends of the siRNA which is enhanced by
CC       interaction with Dcr-2 (PubMed:29040648). This suggests that the
CC       domains may also function to pre-orientate the guide strand prior to
CC       loading into the (AGO2)-containing RNA-induced silencing complex
CC       (siRISC) (PubMed:29040648). Both of the DRBM 1 and 2 domains are
CC       required for optimal Dcr-2 mediated cleavage of 3' overhanging termini
CC       (3'ovr) dsRNAs, whereas only the DRBM 3 domain appears to be necessary
CC       for Dcr-2 mediated cleavage of blunt termini (BLT) dsRNAs
CC       (PubMed:28874570). {ECO:0000269|PubMed:28874570,
CC       ECO:0000269|PubMed:29040648, ECO:0000269|PubMed:34590626,
CC       ECO:0000269|PubMed:36182693}.
CC   -!- DISRUPTION PHENOTYPE: Larval lethal and displays miRNA processing
CC       defects (PubMed:17320391). Embryos do not develop past the first instar
CC       larvae stage (PubMed:17320391). Most females contain ovaries with empty
CC       germaria accompanied by one or two terminal stage egg chambers
CC       (PubMed:17320391). Accumulates pre-miRNAs and displays a reduction in
CC       mature miRNAs (PubMed:17320391). {ECO:0000269|PubMed:17320391}.
CC   -!- DISRUPTION PHENOTYPE: [Isoform PA]: No significant effect on female or
CC       male fertility. {ECO:0000269|PubMed:23063653}.
CC   -!- DISRUPTION PHENOTYPE: [Isoform PB]: Female fertility is severely
CC       reduced whereas male fertility is relatively unaffected
CC       (PubMed:23063653). Females lay very few eggs, and most of the eggs that
CC       are laid have abnormal appendages and do not hatch (PubMed:23063653).
CC       {ECO:0000269|PubMed:23063653}.
CC   -!- DISRUPTION PHENOTYPE: [Isoform PD]: No significant effect on female or
CC       male fertility. {ECO:0000269|PubMed:23063653}.
CC   -!- MISCELLANEOUS: The name 'Loquacious' refers to the mutants being 'very
CC       talkative' as they display a loss of several types of gene silencing.
CC       {ECO:0000269|PubMed:15918769}.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Cytoplasm; Reference proteome; Repeat;
KW   RNA-binding; RNA-mediated gene silencing.
FT   CHAIN           1..465
FT                   /note="Protein Loquacious"
FT                   /id="PRO_0000458898"
FT   DOMAIN          135..206
FT                   /note="DRBM 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00266"
FT   DOMAIN          250..318
FT                   /note="DRBM 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00266"
FT   DOMAIN          393..461
FT                   /note="DRBM 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00266"
FT   REGION          1..392
FT                   /note="Important for homodimerization and interaction with
FT                   Dcr-1"
FT                   /evidence="ECO:0000269|PubMed:26769856"
FT   REGION          1..379
FT                   /note="Not required for interaction with Dcr-1"
FT                   /evidence="ECO:0000269|PubMed:17666393,
FT                   ECO:0000269|PubMed:26769856"
FT   REGION          1..337
FT                   /note="Necessary for enhancing pre-miRNA processing by Dcr-
FT                   1"
FT                   /evidence="ECO:0000269|PubMed:17666393"
FT   REGION          129..322
FT                   /note="Necessary for promoting preferential binding of Dcr-
FT                   2 to the less stably base paired ends of siRNAs"
FT                   /evidence="ECO:0000269|PubMed:29040648"
FT   REGION          129..211
FT                   /note="Sufficient for binding RNA"
FT                   /evidence="ECO:0000269|PubMed:29040648"
FT   REGION          209..249
FT                   /note="Enables simultaneous binding of both DRBM 1 and 2
FT                   domains to dsRNA"
FT                   /evidence="ECO:0000269|PubMed:29040648"
FT   REGION          220..465
FT                   /note="Necessary and sufficient for enhancing processing of
FT                   pre-miRNAs by Dcr-1"
FT                   /evidence="ECO:0000269|PubMed:17666393"
FT   REGION          245..322
FT                   /note="Sufficient for binding RNA"
FT                   /evidence="ECO:0000269|PubMed:29040648"
FT   REGION          308..309
FT                   /note="Necessary for binding pre-miRNA"
FT                   /evidence="ECO:0000269|PubMed:17666393"
FT   REGION          340..465
FT                   /note="Necessary for interaction with Dcr-1"
FT                   /evidence="ECO:0000269|PubMed:17666393"
FT   REGION          392..463
FT                   /note="Sufficent for binding to Dcr-1"
FT                   /evidence="ECO:0000269|PubMed:26769856"
FT   VAR_SEQ         338..383
FT                   /note="Missing (in isoform PA)"
FT                   /id="VSP_062002"
FT   VAR_SEQ         338..383
FT                   /note="PRSSENYYGELKDISVPTLTTQHSNKVSQFHKTLKNATGKKLLKLQ -> NE
FT                   SVKHLFHTKVICFNSPLACVISNVCEMQWRKETKNFALLFTAPQ (in isoform
FT                   PC)"
FT                   /id="VSP_062003"
FT   VAR_SEQ         338..359
FT                   /note="PRSSENYYGELKDISVPTLTTQ -> VSIIQDIDRYEQVSKDFEFIKI (in
FT                   isoform PD)"
FT                   /id="VSP_062004"
FT   VAR_SEQ         360..465
FT                   /note="Missing (in isoform PD)"
FT                   /id="VSP_062005"
FT   VAR_SEQ         384..465
FT                   /note="Missing (in isoform PC)"
FT                   /id="VSP_062006"
FT   MUTAGEN         308..309
FT                   /note="AA->LL: Abolishes interaction with pre-miRNA (pre
FT                   let 7) in the presence of Dcr-1."
FT                   /evidence="ECO:0000269|PubMed:17666393"
FT   MUTAGEN         379..382
FT                   /note="LLKL->AAKA: Strong reduction in Dcr-1 activity."
FT                   /evidence="ECO:0000269|PubMed:26769856"
FT   MUTAGEN         419
FT                   /note="F->A: Strong reduction in Dcr-1 activity."
FT                   /evidence="ECO:0000269|PubMed:26769856"
FT   MUTAGEN         426
FT                   /note="L->R: Decreased binding to Dcr-1."
FT                   /evidence="ECO:0000269|PubMed:26769856"
FT   MUTAGEN         440..465
FT                   /note="Missing: Loss of activity, abolishes interaction
FT                   with Dcr-1 and therefore does not enhance pre-miRNA
FT                   processing by the dicer."
FT                   /evidence="ECO:0000269|PubMed:17666393"
FT   REGION          Q9VJY9-4:338..359
FT                   /note="Required for binding to Dcr-2 and to fully enhance
FT                   Dcr-2 mediated cleavage of 3' overhanging termini (3'ovr)
FT                   and blunt termini (BLT) dsRNAs. However, this region is
FT                   dispensable for binding the dsRNA substrates"
FT                   /evidence="ECO:0000269|PubMed:21245036,
FT                   ECO:0000269|PubMed:28874570"
FT   MUTAGEN         Q9VJY9-4:347
FT                   /note="Y->A: Reduced interaction with Dcr-2."
FT                   /evidence="ECO:0000269|PubMed:35768513"
FT   MUTAGEN         Q9VJY9-4:356
FT                   /note="F->D: Reduced interaction with Dcr-2."
FT                   /evidence="ECO:0000269|PubMed:35768513"
FT   MUTAGEN         Q9VJY9-4:359
FT                   /note="I->D: Reduced interaction with Dcr-2."
FT                   /evidence="ECO:0000269|PubMed:35768513"
**
**   #################    INTERNAL SECTION    ##################
SQ   SEQUENCE   465 AA;  50085 MW;  B69684E6B912F929 CRC64;
     MDQENFHGSS LPQQLQNLHI QPQQASPNPV QTGFAPRRHY NNLVGLGNGN AVSGSPVKGA
     PLGQRHVKLK KEKISAQVAQ LSQPGQLQLS DVGDPALAGG SGLQGGVGLM GVILPSDEAL
     KFVSETDANG LAMKTPVSIL QELLSRRGIT PGYELVQIEG AIHEPTFRFR VSFKDKDTPF
     TAMGAGRSKK EAKHAAARAL IDKLIGAQLP ESPSSSAGPS VTGLTVAGSG GDGNANATGG
     GDASDKTVGN PIGWLQEMCM QRRWPPPSYE TETEVGLPHE RLFTIACSIL NYREMGKGKS
     KKIAKRLAAH RMWMRLQETP IDSGKISDSI CGELEGEPRS SENYYGELKD ISVPTLTTQH
     SNKVSQFHKT LKNATGKKLL KLQKTCLKNN KIDYIKLLGE IATENQFEVT YVDIEEKTFS
     GQFQCLVQLS TLPVGVCHGS GPTAADAQRH AAQNALEYLK IMTKK
//
